U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07806474) titled 'Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia' on Aug. 27.

Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of two different formulations of a food supplement on hair health in healthy Caucasian male subjects aged 35 to 65 years with mild to moderate androgenetic alopecia. The main questions it aims to answer are:

* Whether the two formulations improve hair growth and reduce hair loss after 42 and 84 days, as assessed by phototricogram parameters.

* Whether the two formulations improve hair brightness, and colour lightness after 42 and 84 days, as assessed by spect...